Men's Health
Conference Coverage
Erectile dysfunction: It’s worse than you think
European study finds higher risk of mortality in men reporting dysfunction.
Outcomes Research in Review
Cabazitaxel Improves Progression-Free and Overall Survival in Metastatic Prostate Cancer After Progression on Abiraterone or Enzalutamide
News
Nearly half of STI events go without HIV testing
Missed opportunities for HIV diagnosis have the potential to delay linkage to antiretroviral therapy or PrEP and prevention services.
Article
PSA cancer screening: A case for shared decision-making
Whether to screen for prostate cancer using PSA testing is a difficult decision for many men. Here’s the information you need to help them make an...
News
Suicide attempts up in black U.S. teens
The rate of attempts grew from 1991 to 2017 in black adolescents, according to survey findings, but white adolescents are still more likely to...
FDA/CDC
FDA panel backs Descovy as HIV PrEP for men and transgender women who have sex with men
Outcomes Research in Review
Enzalutamide Improves Progression-Free and Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer
News
ACIP extends HPV vaccine coverage
Committee voted for catch-up vaccination for all individuals through age 26 years, optional for older adults.
Conference Coverage
TITAN trial yields big survival benefits in mCSPC
CHICAGO – Adding apalutamide to androgen deprivation therapy significantly improved overall survival of castration-...
Video
Chronic opioid use linked to low testosterone levels
Hypercortisolism also seen.